Expert consensus on nutritional therapy for patients with ovarian cancer

Chinses Society of Nutritional Oncology

doi:10.16689/j.cnki.cn11-9349/r.2020.04.008

PDF(406 KB)

Electronic Journal of Metabolism and Nutrition of Cancer ›› 2020, Vol. 7 ›› Issue (4) : 418-420. DOI: 10.16689/j.cnki.cn11-9349/r.2020.04.008

Expert consensus on nutritional therapy for patients with ovarian cancer

Chinses Society of Nutritional Oncology

Author information +

History +

Abstract

Ovarian cancer is one of the most common malignant tumors in women, ranking the 5th among the causes of tumor-related death in women. About 70% of newly diagnosed patients and 85% of recurrent patients may be associated with peritoneal metastasis. Ovarian cancer leave the body in a state of high decomposition, which increases the risk of malnutrition, and 23 percent of patients are diagnosed with cachexy. Nutritional status of ovarian cancer patients may be associated with prognosis. Regular assessment helps to assess the nutritional status of patients with ovarian cancer in a comprehensive and accurate manner. Obese women have a higher mortality rate from ovarian cancer, overweight or obese ovarian cancer patients should control their weight, exercise and nutrition treatment can help improve patient survival.

Key words

Ovarian cancer / Nutritional therapy / Expert consensus

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

Chinses Society of Nutritional Oncology. Expert consensus on nutritional therapy for patients with ovarian cancer[J]. Electronic Journal of Metabolism and Nutrition of Cancer. 2020, 7(4): 418-420 https://doi.org/10.16689/j.cnki.cn11-9349/r.2020.04.008

References

1.SIEGEL R L, MILLER K D, JEMAL A. Cancer statistics, 2018 ［J］. CA Cancer J Clin, 2018, 68:7-30.
2.JELOVAC D, ARMSTRONG D K. Recent progress in the diagnosis and treatment of ovarian cancer ［J］. CA Cancer J Clin, 2011, 61:183-203.
3.HILAL Z, REZNICZEK G A, KLENKE R, et al. Nutritional status, cachexia, and anorexia in women with peritoneal metastasis and intraperitoneal chemotherapy: a longitudinal analysis［J］. J Gynecol Oncol, 2017, 28(6):e80.
4.LAKY B, JANDA M, KONDALSAMY-CHENNAKESAVAN S, et al. Pretreatment malnutrition and quality of life-association with prolonged length of hospital stay among patients with gynecological cancer: a cohort study［J］.BMC Cancer, 2010, 25:10:232.
5.MARDAS M, STELMACH-MARDAS M, MADRY R. Body weight changes in patients undergoingchemotherapy for ovariancancer influence progression-free and overall survival［J］.SupportCare Cancer, 2017, 25(3):795-800.
6.ARENDS J, BACHMANN P, Baracos V, et al. ESPEN guidelines on nutrition in cancer patients［J］.Clin Nutr, 2017 , 36(1):11-48.
7.LAKY B, JANDA M, CLEGHORN G, et al. Comparison of different nutritional assessments and body-composition measurements in detecting malnutrition among gynecologic cancer patients［J］.Am J Clin Nutr, 2008, 87(6):1678-1685.
8.陈咏宁，关阳，郑莉，等。妇科恶性肿瘤病人不同营养评估方法的对比分析［J］. 肠外与肠内营养，2017,24（4）:221-224.
9.CAO D X, WU G H, ZHANG B, et al. Resting energy expenditure and body composition in patients with newly detected cancer［J］. Clin Nutr, 2010, 29(1):72-77.
10.ROCK C L, DOYLE C, DEMARK-WAHNEFRIED W, et al. Nutrition and physical activity guidelines for cancer survivors.CA Cancer J Clin［J］,2012, 62(4):242-274.
11.BANDERA E V, KUSHI L H, RODRIGUEZ-RODRIGUEZ L. Nutritional factors in ovarian cancer survival［J］. Nutr Cancer,2009, 61:580-586.
12.BAKER J, JANDA M, GRAVES N, et al. Quality of life after early enteral feeding versus standard care for proven or suspected advanced epithelial ovarian cancer: results from a randomised trial［J］. GynecolOncol, 2015, 137(3):516-522.
13.MENDIVIL A A, RETTENMAIER M A, ABAID L N, et al. The impact of total parenteral nutrition on postoperative recovery in patients treated for advanced stage ovarian cancer［J］. Arch Gynecol Obstet, 2017, 295(2):439-444.
14.BRARD L, WEITZEN S, STRUBEL-LAGAN S L, et al.The effect of total parenteral nutrition on the survival of terminally ill ovarian cancer patients［J］. Gynecol Oncol, 2006, 103(1):176-180.